OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy vs. standard care: a Head-to-Head cancer trial
Disease control CompletedThis trial tested if adding a newer immunotherapy drug (durvalumab) to radiation therapy works better than the standard combination of radiation with an older drug (cetuximab). It was for patients with advanced head and neck cancer who could not safely take the usual chemotherapy…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Researchers analyze Real-World data on advanced throat cancer treatments
Knowledge-focused CompletedThis study collected real-world information from 662 patients in the US with HPV-positive throat cancer that had returned or spread. Researchers analyzed how patients responded to standard treatments like pembrolizumab or nivolumab, with or without chemotherapy. The goal was to g…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Hookipa Biotech GmbH • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC